Consultative Expert Working Group on Research and Development: Financing and Coordination (CEWG)
The CEWG was established in accordance with World Health Assembly Resolution 63.28.
The operative part of the resolution WHA63.28 set out various important criteria for the CEWG process in terms of the nomination of experts by the Member States, its composition, transparency and reporting schedule.
The CEWG was mandated to deepen the analysis of the EWG, in particular, by:
- examining the practical details of four innovative financing sources proposed by the EWG
- reviewing five promising proposals identified by the EWG
- exploring a further six proposals that did not meet EWG criteria
Implicit in the resolution was that the overall terms of reference of the CEWG remain the same as the EWG:
“to examine current financing and coordination of research and development, as well as proposals for new and innovative sources of financing to stimulate research and development related to Type II and Type III diseases and the specific research and development needs of developing countries in relation to Type I diseases.”
The CEWG was also asked to consider additional proposals from Member States and from other stakeholders and to examine the appropriateness of different research and development financing approaches and the feasibility of implementation of these approaches in each of the six WHO regions, with subregional analysis, as appropriate. The CEWG reported to the World Health Assembly in 2012.
Further details on the CEWG can be found in the background paper.
Further details on the 22 groups of proposals featured in the EWG report and reviewed by the CEWG can be found in the summary below.